Introduction

“State of the Art” (SOTA) is one of the most frequently used—and misunderstood—concepts in clinical evaluation.

Most manufacturers think it means: “the latest and most advanced technology.”

But under EU MDR, that interpretation is incomplete—and often incorrect.

SOTA is not about being the newest.
It’s about being clinically acceptable, justified, and aligned with current medical practice.

Understanding this distinction is critical—because a weak SOTA definition is one of the fastest ways to get your Clinical Evaluation Report (CER) challenged by a Notified Body.

What Does “State of the Art” Actually Mean?

In regulatory terms, SOTA refers to:

The current, generally accepted good practice in medicine for a specific indication.

This includes:

• Established treatment methods
• Benchmark devices
• Clinical guidelines
• Safety and performance expectations

SOTA defines the clinical context in which your device exists.

It answers key questions:

• What are clinicians currently using?
• What outcomes are considered acceptable?
• What risks are tolerated?
• Where does your device fit in this landscape?

Why SOTA Is Critical in Clinical Evaluation

Under EU MDR, clinical evaluation is not just about proving your device works.

It’s about demonstrating that:

👉 Your device is safe and effective compared to the current state of the art.

This impacts:

1. Benefit–Risk Analysis

Your device’s benefits must outweigh its risks in comparison to SOTA—not in isolation.

2. Clinical Performance Expectations

Performance is judged relative to what is already achievable in the market.

3. Claim Justification

Any claims (e.g., “improved safety” or “better outcomes”) must be supported against SOTA benchmarks.

4. Identification of Clinical Data Gaps

SOTA helps identify what evidence is required—and what gaps must be addressed through PMCF.

Common Misconceptions About SOTA

❌ “SOTA means the newest technology”

Not necessarily. Older, well-established methods can still represent SOTA if they are widely accepted and clinically effective.

❌ “SOTA is defined by competitors”

Competitor devices are part of SOTA—but not the whole picture. Clinical guidelines and standard practices are equally important.

❌ “One paper is enough to define SOTA”

SOTA requires a comprehensive and balanced literature review, not selective evidence.

❌ “SOTA is optional in CER”

Under EU MDR, SOTA is a mandatory component of clinical evaluation.

How to Properly Establish SOTA

A robust SOTA analysis is structured, systematic, and evidence-based.

1. Define the Clinical Indication

Start with:

• Target condition
• Patient population
• Intended use

SOTA is always indication-specific.
For example, SOTA for wound care differs significantly from SOTA for cardiovascular implants.

2. Identify Current Treatment Options

This includes:

• Medical devices
• Pharmaceutical treatments
• Surgical procedures
• Non-interventional approaches

The goal is to capture the full therapeutic landscape, not just similar devices.

3. Review Clinical Guidelines and Standards

Authoritative sources such as:

• International clinical guidelines
• Professional society recommendations
• Consensus statements

These often define what is considered acceptable medical practice.

4. Analyze Clinical Outcomes and Benchmarks

Key parameters include:

• Effectiveness (e.g., success rates, symptom relief)
• Safety (e.g., complication rates)
• Usability and patient compliance

These benchmarks form the basis for comparing your device.

5. Evaluate Risks and Limitations of Existing Options

Understanding SOTA is not just about strengths—it’s also about gaps.

Ask:

• What are the known limitations of current treatments?
• Where do complications occur?
• What unmet needs exist?

This is where your device can position its value.

6. Maintain Objectivity and Balance

A credible SOTA analysis:

• Includes both favorable and unfavorable data
• Avoids cherry-picking evidence
• Reflects real-world clinical practice

Notified Bodies can easily identify biased analyses—and will challenge them.

How SOTA Impacts Your Clinical Strategy

A well-defined SOTA directly influences your regulatory approach.

1. Clinical Evidence Requirements

If your device:

• Matches SOTA → Literature and equivalence may suffice
• Claims improvement → Stronger clinical data required
• Introduces new risks → Additional evaluation needed

2. PMCF Planning

SOTA helps define:

• What uncertainties remain
• What long-term data is needed
• What endpoints should be monitored

3. Positioning Your Device

Your device must clearly demonstrate one of the following:

• Comparable safety and performance to SOTA
• Equivalent outcomes with added benefits (e.g., usability)
• Improved outcomes with acceptable risks

Without this positioning, your CER lacks context.

Why SOTA Sections Often Fail

Even experienced manufacturers struggle with SOTA.

Common issues include:

❌ Superficial Literature Review

Limited sources that do not reflect the full clinical landscape.

❌ Device-Centric Approach

Focusing only on similar devices instead of all treatment options.

❌ Lack of Clinical Context

Failing to connect data to real-world practice.

❌ No Clear Conclusion

Listing data without synthesizing what SOTA actually is.

What Notified Bodies Expect

Notified Bodies are not looking for volume—they are looking for clarity and justification.

A strong SOTA section should:

• Clearly define current clinical practice
• Identify benchmarks for safety and performance
• Highlight limitations and unmet needs
• Provide a logical basis for evaluating your device

Most importantly, it should answer:

How does this device compare to what is already accepted as safe and effective?

Final Thoughts

SOTA is not just a regulatory requirement—it is the foundation of clinical evaluation.

It defines:

• What “safe” means
• What “effective” looks like
• What evidence is required

Without a strong SOTA, your Clinical Evaluation Report becomes disconnected from reality.

And under EU MDR, that is not acceptable.

Because regulators are not asking:
👉 “Does your device work?”

They are asking:
👉 “Does your device work—compared to what already exists?”

That difference is where most submissions succeed—or fail.